Provider review
OrderlyMeds review
$74/mo intro rate for semaglutide doubles to $149/mo after month one
The $74 a month for semaglutide is a first-month rate that becomes $149; tirzepatide goes $149 then $299. Brand drugs are sold at full retail — Zepbound $1,498. The plan also stacks "$1,355 of value" in guides and webinars worth discounting mentally.
Received an FDA warning letter in June 2026 — see the FDA’s warning-letter database.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
OrderlyMeds (OrderlyMeds LLC) is a LegitScript-certified telehealth platform in all 50 states, offering compounded semaglutide and tirzepatide alongside full-retail brand-name Zepbound and Wegovy access. Its advertised entry prices — $74/mo semaglutide, $149/mo tirzepatide — are confirmed-live introductory rates that roughly double after the first month, to $149/mo and $299/mo respectively, per the site's own pricing data. The compounding pharmacy itself is never named beyond a generic 'U.S.-based licensed pharmacy' claim, and the plan bundles a stack of extras marketed with inflated dollar values ('$648 value' webinars, and similar) that read more like marketing padding than real added cost savings.
OrderlyMeds is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want a low, confirmed-live introductory rate and are comfortable with it roughly doubling after month one
- You want access to full-retail brand-name Zepbound or Wegovy alongside compounded options, all from one provider
- You want a provider in all 50 states
Look elsewhere if
- You want the ongoing (post-intro) rate to be the number you budget around from day one
- You want a named compounding pharmacy rather than a generic 'U.S.-based licensed pharmacy' claim
- You're skeptical of bundled extras marketed with large 'value' price tags attached
What it actually costs
What they advertise
Compounded semaglutide from $74/mo (intro rate) on orderlymeds.com.
What you actually pay, month to month
$149/mo is OrderlyMeds' own stated regular rate once the introductory month ends.
The commitment trap
The $74/mo figure is an explicitly introductory rate; OrderlyMeds' own pricing data shows the regular ongoing rate is $149/mo, roughly double.
Checked live on OrderlyMeds's own site at https://orderlymeds.com in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what OrderlyMeds bundles in, and what it does not.
Clinician consult
Doctor-led orientation and virtual consults.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Private community access.
Injection supplies
Not itemized.
Shipping
Discreet shipping.
Pharmacy, labs and oversight
The pharmacy
Described only as a "U.S.-based licensed pharmacy," not individually named.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states via the site's own FAQ schema.
The honest cons
The part they would rather you skipped
The $74/mo semaglutide headline is real — but it's an introductory rate that OrderlyMeds' own pricing data shows roughly doubling to $149/mo after the first month, and the bundled extras are marketed with inflated dollar values ('$648 value' webinars, '$299 value' orientation) that pad the perceived deal without a named compounding pharmacy to check the medication itself against.
- Introductory pricing roughly doubles after month one ($74 to $149/mo semaglutide; $149 to $299/mo tirzepatide)
- Compounding pharmacy described only generically, not individually named
- Bundled extras marketed with inflated 'value' price tags rather than a straightforward all-in cost
- Brand-name Zepbound and Wegovy priced at full retail, over $1,400/mo, with no discount applied
None of this is unique to OrderlyMeds — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. OrderlyMeds is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect OrderlyMeds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on OrderlyMeds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.